Sendvario vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 523,994 | 497,455 | 577,885 | 520,286 | 591,316 | 695,950 | 720,363 | 739,584 |
| Profit before tax | 3,048 | 996 | 7,410 | 5,757 | 4,630 | 11,382 | 11,549 | 13,342 |
| Net profit | 2,498 | 841 | 5,956 | 4,660 | 3,879 | 9,634 | 9,800 | 11,098 |
| Equity | 77,222 | 78,043 | 83,998 | 88,660 | 92,536 | 102,170 | 111,970 | 123,069 |
| Liabilities | 75,026 | 66,505 | 70,827 | 75,180 | 107,609 | 79,220 | 77,957 | 68,732 |
| Non-current assets | 14,729 | 8,124 | 5,212 | 7,527 | 5,451 | 53,966 | 43,663 | 34,685 |
| Current assets | 137,303 | 136,213 | 149,434 | 156,141 | 194,643 | 126,835 | 145,858 | 156,836 |
| Total assets | 152,032 | 144,337 | 154,646 | 163,668 | 200,094 | 180,801 | 189,521 | 191,521 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 42,775 | 48,270 | 44,800 |
| Social insurance contributions | - | - | - | - | - | 25,728 | 30,797 | 13,184 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -0.3% | -5.1% | +16.2% | -10.0% | +13.7% | +17.7% | +3.5% | +2.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.6% | 0.6% | 3.9% | 2.8% | 1.9% | 5.3% | 5.2% | 5.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 3.2% | 1.1% | 7.1% | 5.3% | 4.2% | 9.4% | 8.8% | 9.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.5% | 0.2% | 1.0% | 0.9% | 0.7% | 1.4% | 1.4% | 1.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.6% | 0.2% | 1.3% | 1.1% | 0.8% | 1.6% | 1.6% | 1.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 0.9 | 0.8 | 0.8 | 1.2 | 0.8 | 0.7 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 87,332 | 89,097 | 115,577 | 104,057 | 126,710 | 157,572 | 149,042 | 170,675 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Sendvario vaistinė - Social security debts
The company had no debts to Sodra
Sendvario vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-20 | 2026-03-22 | 0.23 |
| 2026-02-27 | 2026-03-08 | 0.21 |
| 2026-02-21 | 2026-02-26 | 812.99 |
| 2025-09-28 | 2025-09-29 | 41.58 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sendvario vaistine, UAB (code 141412880) is a private limited liability company operating in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €739.6K, up 2.7% year on year and 6.3% over two years. Net profit reached €11.1K, slightly above the €9.8K reported in 2024 and €9.6K in 2023, while the profit margin improved to 1.5% from 1.4% in the previous two years. The revenue and profit trajectory therefore shows steady, moderate growth rather than sharp expansion. On the balance sheet, total assets increased to €191.5K in 2025 from €189.5K in 2024 and €180.8K in 2023. Equity rose to €123.1K, liabilities declined to €68.7K, and the equity ratio stood at 64.3%. Long-term assets decreased to €34.7K, while short-term assets increased to €156.8K. Key performance indicators for 2025 include ROE of 9.0%, ROA of 5.8%, debt-to-equity of 0.56, and asset turnover of 3.86x. Revenue per employee was €184.9K, indicating solid productivity.